Rapid Dose Extends Financing Window

Rapid Dose Therapeutics Corp (TSE:DOSE) has released an update.

Rapid Dose Therapeutics Corp., a Canadian biotech firm, has announced an extension for closing its private placement financing, aiming to raise up to $6 million through the issuance of over 35 million common shares at $0.17 each. The financing is now set to close by June 24, 2024, with all securities being subject to a four-month hold period. The company is known for its QuickStrip™ product, a fast-dissolving oral film that delivers active ingredients directly into the bloodstream.

For further insights into TSE:DOSE stock, check out TipRanks’ Stock Analysis page.